Beschreibung
Quality of life assessment results from the IBS-QoL questionnaire, comparing improvements in daily functioning, emotional health, and dietary restrictions between probiotic and placebo groups.
Figure 5
ChartSource Paper
Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.Cite This Figure
![Figure 5: Quality of life assessment results from the IBS-QoL questionnaire, comparing improvements in daily functioning, emotional health, and dietary restrictions between probiotic and placebo groups.]() > Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." *Nutrients*, 2020. PMID: [32019158](https://pubmed.ncbi.nlm.nih.gov/32019158/)
<figure> <img src="" alt="Quality of life assessment results from the IBS-QoL questionnaire, comparing improvements in daily functioning, emotional health, and dietary restrictions between probiotic and placebo groups." /> <figcaption>Figure 5. Quality of life assessment results from the IBS-QoL questionnaire, comparing improvements in daily functioning, emotional health, and dietary restrictions between probiotic and placebo groups.<br> Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32019158/">32019158</a></figcaption> </figure>